MyMD Pharmaceuticals's total assets for Q were $21.83M, a decrease of -13.56% from the previous quarter. GB:0A8D total liabilities were $5.72M for the fiscal quarter, a -60.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.